BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37043890)

  • 1. Immunological scars after cure of hepatitis C virus infection: Long-HepC?
    Cornberg M; Mischke J; Kraft AR; Wedemeyer H
    Curr Opin Immunol; 2023 Jun; 82():102324. PubMed ID: 37043890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse inflammaging: Long-term effects of HCV cure on biological age.
    Oltmanns C; Liu Z; Mischke J; Tauwaldt J; Mekonnen YA; Urbanek-Quaing M; Debarry J; Maasoumy B; Wedemeyer H; Kraft ARM; Xu CJ; Cornberg M
    J Hepatol; 2023 Jan; 78(1):90-98. PubMed ID: 36152762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?
    Isfordink CJ; Maan R; de Man RA; van Erpecum KJ; van der Meer AJ
    Eur J Intern Med; 2021 Dec; 94():6-14. PubMed ID: 34563447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders.
    Isfordink CJ; van Erpecum KJ; Fischer K; van der Valk PR; van Vulpen LFD; Schutgens REG; Arends JE; Mauser-Bunschoten EP
    Haemophilia; 2023 Jan; 29(1):106-114. PubMed ID: 36184751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic HCV infection: An internist's opinion (Part 2)].
    Zubkin ML; Chervinko VI; Ovchinnikov YV; Kryukov EV; Kotenko ON
    Ter Arkh; 2016; 88(11):138-148. PubMed ID: 28635834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthroughs in hepatitis C research: from discovery to cure.
    Manns MP; Maasoumy B
    Nat Rev Gastroenterol Hepatol; 2022 Aug; 19(8):533-550. PubMed ID: 35595834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of hepatitis C cure with antivirals: why test and treat?
    Lledó G; Benítez-Gutiérrez L; Arias A; Requena S; Cuervas-Mons V; de Mendoza C
    Future Microbiol; 2019 Mar; 14():425-435. PubMed ID: 30900911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
    Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
    J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
    Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
    J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy.
    Amaddeo G; Nguyen CT; Maillé P; Mulé S; Luciani A; Machou C; Rodrigues A; Regnault H; Mallat A; Laurent A; Lafdil F; Hézode C; Pawlotsky JM; Calderaro J
    Liver Int; 2020 Jan; 40(1):74-82. PubMed ID: 31444947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients.
    Lybeck C; Brenndörfer ED; Sällberg M; Montgomery SM; Aleman S; Duberg AS
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):506-513. PubMed ID: 30461522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The curing regimens of HCV: A SWOT analysis.
    Cornberg M; Manns MP
    Antivir Ther; 2022; 27(1-2):13596535211072672. PubMed ID: 35491553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment.
    Park SJ; Hahn YS
    Clin Mol Hepatol; 2023 Jan; 29(1):65-76. PubMed ID: 35957546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful.
    Abdelhamed W; El-Kassas M
    J Viral Hepat; 2023 Feb; 30(2):148-159. PubMed ID: 36461645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE GORDON WILSON LECTURE: THE HEPATITIS C VIRUS: FROM HIPPOCRATES TO CURE.
    Alter HJ
    Trans Am Clin Climatol Assoc; 2019; 130():104-118. PubMed ID: 31516174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis C in Asia: when East meets West.
    Yu ML; Chuang WL
    J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefits of hepatitis C virus cure: Every rose has thorns.
    Salmon D; Mondelli MU; Maticic M; Arends JE;
    J Viral Hepat; 2018 Apr; 25(4):320-328. PubMed ID: 29112304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity.
    Mondelli MU; Ottolini S; Oliviero B; Mantovani S; Cerino A; Mele D; Varchetta S
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.
    Martinez MA; Franco S
    Adv Exp Med Biol; 2021; 1322():139-157. PubMed ID: 34258740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.